Delos Wealth Advisors’s Boston Scientific BSX Stock Holding History

Delos Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17	Closed	-$1.62K	–	267
2025 Q4	$1.62K	Hold	17	–	–	﹤0.01%	233
2025 Q3	$1.66K	Sell	17 -74	-81%	-$7.66K	﹤0.01%	249
2025 Q2	$9.78K	Buy	+91	New	+$9.21K	0.01%	174
2025 Q1	–	Sell	-74	Closed	-$6.61K	–	73
2024 Q4	$6.61K	Buy	+74	New	+$6.51K	0.01%	125
2024 Q1	–	Sell	-13	Closed	-$752	–	362
2023 Q4	$752	Hold	13	–	–	﹤0.01%	211
2023 Q3	$702	Hold	13	–	–	﹤0.01%	251
2023 Q2	$704	Hold	13	–	–	﹤0.01%	250
2023 Q1	$651	Hold	13	–	–	﹤0.01%	268
2022 Q4	$602	Hold	13	–	–	﹤0.01%	276
2022 Q3	$1K	Buy	+13	New	+$522	﹤0.01%	212
2022 Q1	–	Sell	-136	Closed	-$6K	–	273
2021 Q4	$6K	Buy	+136	New	+$5.71K	0.01%	274

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Delos Wealth Advisors's BSX Position: Q1 2026 in Review

Delos Wealth Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 17 shares — an estimated $1.62K sold.

Delos Wealth Advisors first reported a position in BSX in Q4 2021 and held it in 11 quarters. The position peaked at $9.78K in Q2 2025. 1,678 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Delos Wealth Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Delos Wealth Advisors sold 17 Boston Scientific shares in Q1 2026, an estimated $1.62K.
Delos Wealth Advisors first reported a position in Boston Scientific in Q4 2021 and held it in 11 quarters.
Delos Wealth Advisors's Boston Scientific position peaked at $9.78K in Q2 2025.
1,678 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Delos Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.